C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 14/485 (2006.01) C07K 16/30 (2006.01)
Patent
CA 2629095
The present invention encompasses EGFR specific monoclonal antibodies, or antigen-binding portions thereof. These antibodies, or antigen-binding portions thereof, have high affinity for EGFR, inhibit the activation of EGFR, and are useful for the treatment of EGFR mediated cancers.
La présente invention concerne des anticorps monoclonaux spécifiques au récepteur du facteur de croissance épidermique (EGFR) ou leurs parties de liaison à l~antigène. Ces anticorps, ou leurs parties de liaison à l~antigène, présentent une forte affinité à l~EGFR, inhibent l~activation de l~EGFR et se révèlent utiles lors du traitement des cancers induits par l~EGFR.
Beidler Catherine Brautigam
Vasserot Alain Philippe
Watkins Jeffry Dean
Eli Lily And Company
Gowling Lafleur Henderson Llp
LandOfFree
Anti-egfr antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-egfr antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-egfr antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1444184